SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160326161A1
SERIAL NO

15220949

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Embodiments of the disclosure relate to selectively substituted quinoline compounds that act as antagonists or inhibitors for Toll-like receptors 7 and/or 8, and their use in pharmaceutical compositions effective for treatment of systemic lupus erythematosus (SLE) and lupus nephritis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EISAI R&D MANAGEMENT CO LTDTOKYO JAPAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
CARLSON, Eric Merrimack, US 90 1365
DAVIS, Heather Haverhill, US 24 641
ENDO, Atsushi Andover, US 126 1749
HANSEN, Hans Somerville, US 49 2075
HAWKINS, Lynn Concord, US 20 207
ISHIZAKA, Sally Weston, US 12 118
MACKEY, Matthew Melrose, US 12 119
OGAWA, Chikako Basel, CH 7 54
SCHILLER, Shawn Haverhill, US 28 273

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation